ArticleTobacco control2025
Estimating tobacco product availability prevalence in medical cannabis dispensaries in Oklahoma, USA, 2024.
Article in Tobacco control, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
introductionAs an increasing number of US states legalise cannabis use, they are faced with creating policies to regulate cannabis sales. In this observational cross-sectional study in Oklahoma, we estimate the prevalence of medical cannabis dispensaries selling tobacco products, which may increase the risk of tobacco use and cannabis co-use due to increased exposure to tobacco retail marketing and availability.
methodsWe downloaded publicly available medical cannabis dispensary and tobacco licence lists from the Oklahoma Medical Marijuana Authority and the Oklahoma State Department of Health (April 2024). Using fuzzy matching techniques, we identified businesses that were on both the cannabis and tobacco licensing lists. Then, we conducted online Google business and image searches to assess the availability or marketing (yes/no) of tobacco products in cannabis dispensaries by looking for tobacco products (eg, cigarillos) and marketing (eg, cigarette ads on window fronts).
resultsThere were 2166 licensed medical cannabis dispensaries and 4974 licensed tobacco retailers in Oklahoma. We identified 56 licensed cannabis dispensaries that potentially sold tobacco (56/2166=2.6% of all dispensaries) and 91 licensed tobacco retailers that potentially sold cannabis (91/4974=1.8% of all tobacco retailers).
conclusionsAs cannabis legalisation increases, cannabis dispensaries and tobacco retailers may begin selling both substances, potentially leading to initiation, increased use and co-use and decreased cessation of tobacco and cannabis products. To address these health risks, state and local laws that clearly prohibit retailers from selling both substances simultaneously are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.